Seiwerth, S., Sikiric, P., Grabarevic, Z., Zoricic, I., Hanzevacki, M., Ljubanovic, D., Coric, V., Konjevoda, P., Petek, M., Rucman, R., Turkovic, B., Perovic, D., Mikus, D., Jandrijevic, S., Medvidovic, M., Tadic, T., Romac, B., Kos, J., Peric, J.,
Some patients experience significant fat loss
This code does NOT map to an HCC and carries no RAF weight appropriate coding prevents risk score inflation from historical codes assigned to resolved conditions
It typically presents prior to age 30 and occurs more frequently in patients with European or Ashkenazi Jewish heritage
For educational reference only
Both compounds act as growth hormone secretagogues but via distinct mechanisms, making this combination highly effective for stimulating natural GH pulses without increasing prolactin or cortisol levels